Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies
Authors
Keywords
-
Journal
Hematology
Volume 22, Issue 10, Pages 585-591
Publisher
Informa UK Limited
Online
2017-05-26
DOI
10.1080/10245332.2017.1328165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of Carfilzomib-Associated Cardiac Adverse Events
- (2016) Joseph Mikhael Clinical Lymphoma Myeloma & Leukemia
- Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
- (2016) Meletios A Dimopoulos et al. LANCET ONCOLOGY
- Cancer Chemotherapy and Cardiac Arrhythmias: A Review
- (2015) Juan Tamargo et al. DRUG SAFETY
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bortezomib-induced acute congestive heart failure: a case report and review of literature
- (2014) Ashish Subedi et al. ANNALS OF HEMATOLOGY
- Incidence and Risk of Cardiotoxicity Associated with Bortezomib in the Treatment of Cancer: A Systematic Review and Meta-Analysis
- (2014) Yi Xiao et al. PLoS One
- Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database
- (2013) Benjamin Honton et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
- (2013) D. Siegel et al. HAEMATOLOGICA
- Severe Heart Failure after Bortezomib Treatment in a Patient with Multiple Myeloma: A Case Report and Review of the Literature
- (2012) Margarita Bockorny et al. ACTA HAEMATOLOGICA
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- Bortezomib-Induced Congestive Cardiac Failure in a Patient with Multiple Myeloma
- (2011) Ajay Gupta et al. Cardiovascular Toxicology
- Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma
- (2010) Hiroyuki Takamatsu et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Myocardial scarring following chemotherapy for multiple myeloma detected using late gadolinium hyperenhancement cardiovascular magnetic resonance
- (2010) Paul WX Foley et al. Journal of Cardiovascular Medicine
- Epidemiology and risk profile of heart failure
- (2010) Anh L. Bui et al. Nature Reviews Cardiology
- Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma
- (2010) Won-Seop Lee et al. YONSEI MEDICAL JOURNAL
- Complete heart block secondary to bortezomib use in multiple myeloma
- (2010) Constantin A Dasanu JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search